In murine OVA-asthma, oral administration of EGCG significantly reduced bronchoalveolar eosinophilia, serum IgE levels, and the expression of Th2 cytokines such as IL-4, IL-5, and IL-13. The gene discussed is IL13; the disease is asthma.